ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Embargoed until March 13, 4:00 p.m. ET:

Improving Immunohistochemistry Capability for Pediatric Cancer Care in Central America and Caribbean Region: A Report from the AHOPCA Pathology Working Group (JGO: Special Article)
Teresa C. Santiago, et al.
Request this article

Acute Complications after High-Dose Chemotherapy and Stem Cell Rescue in Pediatric Patients with High Risk Neuroblastoma Treated in Countries with Different Resources (JGO: Original Report)
Kevin Scott Baker, et al.
Request this article

Palliative Care Program Development in a Low-Middle Income Country: Delivery of Care by a Non-Governmental Organization in India (JGO: Original Report)
M.R. Rajagopal, et al.
Request this article

Embargoed until March 12, 4:00 p.m. ET:

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT) (JCO: Original Report)
Richard Carvajal, et al.
Request this article

Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer (JCO: Original Report)
Steven Katz, et al.
Request this article

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous Non‒Small-Cell Lung Cancer (JCO: Original Report)
Shun Lu, et al.
Request this article

Embargoed until March 9, 4:00 p.m. ET:

US Food and Drug Administration Pooled Analysis to Assess the Impact of Bone-Only Metastatic Breast Cancer on Clinical Trial Outcomes and Radiographic Assessments (JCO: Original Report)
Suparna Wedam, et al.
Request this article

Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer (JCO: Original Report)
Alicia Morgans, et al.
Request this article

Clinical Value of RNA-sequencing-based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: a Report From the Population-based Multicenter SCAN-B Study (JCO PO: Original Report)
Lao H. Saal, et al.
Request this article

Embargoed until March 7, 4:00 p.m. ET:

Implementing a Childhood Cancer Outcomes Surveillance System within a Population-Based Cancer Registry (JGO: Original Report)
Oscar Ramirez, et al.
Request this article

D3Oncoprint: Standalone software to visualize and dynamically explore annotated genomic mutation files (JCO CCI: Original Report)
Richard Simon, et al.
Request this article

Embargoed until March 6, 4:00 p.m. ET:

Development of a Radiation Oncology-Specific Prospective Data Registry for Research and Quality Improvement: A Clinical Workflow-Based Solution (JCO CCI: Original Report)
Allen Chen, et al.
Request this article

Oncologists' Views Regarding the Role of Electronic Health Records for Care Coordination (JCO CCI: Original Report)
Onur Asan, et al.
Request this article

A Pilot Study of Personalized Video Visit Summaries for Patients with Cancer (JCO CCI: Original Report)
John Krauss, et al.
Request this article

Embargoed until March 5, 4:00 p.m. ET:

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review (JCO: ASCO Special Article)
Patricia Hurley, et al.
Request this article

Illness Understanding and End-of-Life Care Communication and Preferences for Patients with Advanced Cancer in South Africa (JGO: Original Report)
Megan Shen, et al.
Request this article

A Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients with Metastatic Cancer with an Unknown or Unclear Diagnosis (JCO PO: Original Report)
Sachdev Thomas, et al.
Request this article

Embargo Information

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well.  Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.